Forge Biologics Revenue and Competitors

Location

#1314

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Forge Biologics's estimated annual revenue is currently $82M per year.(i)
  • Forge Biologics's estimated revenue per employee is $217,000
  • Forge Biologics's total funding is $330M.

Employee Data

  • Forge Biologics has 378 Employees.(i)
  • Forge Biologics grew their employee count by 4% last year.

Forge Biologics's People

NameTitleEmail/Phone
1
Co-Founder and COOReveal Email/Phone
2
VP Client DevelopmentReveal Email/Phone
3
SVP Medical AffairsReveal Email/Phone
4
SVP Regulatory AffairsReveal Email/Phone
5
VP Process DevelopmentReveal Email/Phone
6
SVP, Head Business DevelopmentReveal Email/Phone
7
VP Quality ManagementReveal Email/Phone
8
SVPReveal Email/Phone
9
SVP, Finance & Investor RelationsReveal Email/Phone
10
SVP, Clinical AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is Forge Biologics?

Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.

keywords:N/A

$330M

Total Funding

378

Number of Employees

$82M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Forge Biologics News

2022-04-06 - Forge Biologics to Present at Chardan's 6th Annual Genetic ...

Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge's mission is to...

2021-04-29 - Forge Biologics Raises $120M in Series B Financing

Forge Biologics, a Columbus, Ohio-based gene therapy-focused contract development and manufacturing organization, closed a $120m Series B financing. The round was led by RA Capital Management with participation from Perceptive Advisors and related affiliates, Surveyor Capital (a Citadel company ...

2021-04-29 - Forge Biologics : Announces Closing of $120 Million Series B Financing

Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced the closing of a $120 million Series B financing. The financing was led by RA Capital Management with participation from Perceptive Advisors and related affiliates, Surveyor Capital (a Ci ...

2021-01-04 - Forge Biologics Announces FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Trial (RESKUE) of FBX-101 Gene Therapy for Patients with Krabbe Disease USA - English España - español France - Français Deutschland - Deutsch

COLUMBUS, Ohio, Jan. 4, 2021 /PRNewswire/ -- Forge Biologics Inc., a gene therapy manufacturing and development company, today announced that the company has received FDA clearance of the Investigational New Drug (IND) to initiate a Phase 1/2 clinical trial evaluating its novel, first-in-human ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$104M37816%N/A
#2
$35M3786%N/A
#3
$85.3M3796%N/A
#4
$62.7M380-29%$609M
#5
$86M382N/AN/A